Latest News for: myc

Edit

Grove Biopharma Reports Preclinical Study in Nature Communications Demonstrating a Novel Approach to MYC and ...

The Galveston Daily News 24 Feb 2026
CHICAGO--(BUSINESS WIRE)--Feb 24, 2026-- ....
Edit

Grove Biopharma Reports Preclinical Study in Nature Communications Demonstrating a Novel Approach to MYC and KRAS Degradation

Pharmiweb 24 Feb 2026
The peer-reviewed study, titled “Heterobifunctional proteomimetic polymers for targeted degradation of MYC and KRAS,” was published today in Nature Communications ... “MYC and KRAS drive a significant ...
Edit

Dewpoint Therapeutics Selects First-in-Class MYC Condensate Modulator Development Candidate

Nasdaq Globe Newswire 11 Feb 2026
Dewpoint Therapeutics selects a first-in-class small molecule development candidate for multiple cancers in which MYC dependence is a central driver ... .
Edit

MYC Targeting Therapies Market Research Report 2026-2030, Profiles of Genetic Leap, Curigin, IDP Pharma, Incurix, ...

Business Wire 31 Jan 2026
DUBLIN--(BUSINESS WIRE)--The "MYC ... > 10 Therapies MYC Targeting Drugs Clinical Trials Insig .
Edit

MYC Targeting Therapies Market Research Report 2026-2030: 10 Therapies in Clinical Trials, 5 Targeting Platforms, ...

Nasdaq Globe Newswire 23 Jan 2026
MYC targeted therapies offer significant market opportunities, driven by their potential as oncogenic drivers in diverse tumors.
Edit

MYC: Youth voices must guide new ministry team

The Star 18 Dec 2025
KUALA LUMPUR ... Read full story .
  • 1

Article Search

tools
×
×
×
×